<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>8065</number>
    <updateDate>2025-01-24T19:33:47Z</updateDate>
    <updateDateIncludingText>2025-01-24T19:33:47Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2024-04-18</introducedDate>
    <congress>118</congress>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 170, Number 68 (Thursday, April 18, 2024)][House][Pages H2521-H2522]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. COSTA:H.R. 8065.[[Page H2522]]Congress has the power to enact this legislation pursuantto the following:Article I, Section 8The single subject of this legislation is:To strengthen regulations surrounding the sale of highlyinfectious agents and high-containment laboratories.&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2024-04-26T13:39:22Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2024-04-18T13:01:00Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2024-04-26</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2024-04-18</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2024-04-18</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-04-18</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>C001059</bioguideId>
        <fullName>Rep. Costa, Jim [D-CA-21]</fullName>
        <firstName>Jim</firstName>
        <lastName>Costa</lastName>
        <party>D</party>
        <state>CA</state>
        <district>21</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>K000401</bioguideId>
        <fullName>Rep. Kiley, Kevin [R-CA-3]</fullName>
        <firstName>Kevin</firstName>
        <lastName>Kiley</lastName>
        <party>R</party>
        <state>CA</state>
        <district>3</district>
        <sponsorshipDate>2024-04-18</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>V000129</bioguideId>
        <fullName>Rep. Valadao, David G. [R-CA-22]</fullName>
        <firstName>David</firstName>
        <lastName>Valadao</lastName>
        <party>R</party>
        <state>CA</state>
        <middleName>G.</middleName>
        <district>22</district>
        <sponsorshipDate>2024-05-01</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects/>
      <policyArea>
        <name>Health</name>
        <updateDate>2024-06-24T18:31:08Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2024-04-18</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2025-01-24T19:32:10Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Preventing Illegal Laboratories and Protecting Public Health Act of 2024&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill requires sellers of highly infectious agents to maintain a logbook of sales and requires a designated official to evaluate high-containment laboratories. Sellers of highly infectious agents must maintain an electronic list, or logbook, with specific information on each sale. Sales are prohibited unless the prospective purchaser provides identification and signs the logbook. A purchaser that falsifies a logbook may be subject to criminal penalties. The Administration for Strategic Preparedness and Response must administer the logbook program and maintain a list of all highly infectious agents.&amp;nbsp;&lt;/p&gt;&lt;p&gt;In addition, a federal official, designated by the National Security Advisor, must oversee a periodic strategic evaluation of high-containment laboratories in the United States. Each strategic evaluation must include an assessment and national standards, developed by the designated official, for the development and operation of high-containment laboratories. The designated official must maintain a team to serve as the federal governmentâ€™s primary point of contact for state and local agencies on issues relating to laboratory biosafety and biosecurity.&amp;nbsp;&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Preventing Illegal Laboratories and Protecting Public Health Act of 2024</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Preventing Illegal Laboratories and Protecting Public Health Act of 2024</title>
        <updateDate>2024-06-11T15:55:07Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Preventing Illegal Laboratories and Protecting Public Health Act of 2024</title>
        <updateDate>2024-05-24T13:32:58Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To require the Secretary of Health and Human Services, acting through the Assistant Secretary for Preparedness and Response, to carry out a program under which the Secretary requires each regulated seller of a highly infectious agent to comply with certain logbook requirements, and for other purposes.</title>
        <updateDate>2024-05-06T13:56:28Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2024-04-18T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr8065ih/xml/BILLS-118hr8065ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2024-04-26</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
